US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 11.900
  • +0.710+6.34%
Close Nov 5 16:00 ET
289.02MMarket Cap-8887P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q1)Mar 31, 2021
Total revenue
0
-74.62%251K
579.21%33.49M
0
-26.63%989K
146.30%4.93M
1,114.41%1.35M
2M
1.42M
111K
Operating revenue
--0
--0
567.67%32.92M
--0
-26.63%989K
146.30%4.93M
1,114.41%1.35M
--2M
--1.42M
--111K
Cost of revenue
Gross profit
Operating expense
5.67%16.19M
-21.06%14.74M
-0.92%64.16M
15.32M
38.64%18.68M
17.16%64.76M
-44.51%13.47M
202.52%55.27M
111.21%12.81M
24.28M
Selling and administrative expenses
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--4.06M
3.69%3.91M
61.50%20.78M
41.78%3.77M
190.65%12.86M
154.72%4.32M
--2.66M
-General and administrative expense
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--4.06M
3.69%3.91M
61.50%20.78M
41.78%3.77M
190.65%12.86M
154.72%4.32M
--2.66M
Research and development costs
9.51%12.33M
-24.47%11.16M
14.25%50.25M
--11.26M
52.20%14.77M
3.71%43.98M
-55.12%9.71M
206.32%42.41M
94.33%8.49M
--21.62M
Operating profit
-5.67%-16.19M
18.07%-14.49M
48.74%-30.67M
-15.32M
-45.89%-17.69M
-12.31%-59.83M
49.84%-12.12M
-191.57%-53.27M
-87.77%-11.39M
-24.17M
Net non-operating interest income expense
-32.81%-676K
-36.52%650K
95.90%2.54M
-509K
1.02M
1.29M
0
0
Non-operating interest income
-32.81%-676K
-36.52%650K
95.90%2.54M
---509K
--1.02M
--1.29M
----
--0
--0
----
Non-operating interest expense
----
----
----
----
----
----
----
--0
--0
----
Other net income (expense)
7,612.90%2.33M
-128.30%-121K
156.00%512K
-31K
-53K
101.08%200K
-3,989.52%-18.55M
0
-18.55M
Gain on sale of security
--2.35M
---268K
--707K
----
----
----
----
----
----
----
Other non- operating income (expenses)
25.81%-23K
377.36%147K
-197.50%-195K
---31K
---53K
101.08%200K
----
-3,989.52%-18.55M
--0
---18.55M
Income before tax
8.35%-14.54M
16.47%-13.96M
52.65%-27.62M
-15.86M
-37.88%-16.72M
18.78%-58.34M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
Income tax
35.85%72K
53K
Net income
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
Net income continuous Operations
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
---15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
---42.72M
Minority interest income
Net income attributable to the parent company
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
Basic earnings per share
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-1.6943
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
-299.23%-7.6723
-92.08%-1.2169
-4.5636
Diluted earnings per share
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-1.6943
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
-299.23%-7.6723
-92.08%-1.2169
-4.5636
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q1)Mar 31, 2021
Total revenue 0-74.62%251K579.21%33.49M0-26.63%989K146.30%4.93M1,114.41%1.35M2M1.42M111K
Operating revenue --0--0567.67%32.92M--0-26.63%989K146.30%4.93M1,114.41%1.35M--2M--1.42M--111K
Cost of revenue
Gross profit
Operating expense 5.67%16.19M-21.06%14.74M-0.92%64.16M15.32M38.64%18.68M17.16%64.76M-44.51%13.47M202.52%55.27M111.21%12.81M24.28M
Selling and administrative expenses -4.98%3.86M-8.17%3.59M-33.04%13.91M--4.06M3.69%3.91M61.50%20.78M41.78%3.77M190.65%12.86M154.72%4.32M--2.66M
-General and administrative expense -4.98%3.86M-8.17%3.59M-33.04%13.91M--4.06M3.69%3.91M61.50%20.78M41.78%3.77M190.65%12.86M154.72%4.32M--2.66M
Research and development costs 9.51%12.33M-24.47%11.16M14.25%50.25M--11.26M52.20%14.77M3.71%43.98M-55.12%9.71M206.32%42.41M94.33%8.49M--21.62M
Operating profit -5.67%-16.19M18.07%-14.49M48.74%-30.67M-15.32M-45.89%-17.69M-12.31%-59.83M49.84%-12.12M-191.57%-53.27M-87.77%-11.39M-24.17M
Net non-operating interest income expense -32.81%-676K-36.52%650K95.90%2.54M-509K1.02M1.29M00
Non-operating interest income -32.81%-676K-36.52%650K95.90%2.54M---509K--1.02M--1.29M------0--0----
Non-operating interest expense ------------------------------0--0----
Other net income (expense) 7,612.90%2.33M-128.30%-121K156.00%512K-31K-53K101.08%200K-3,989.52%-18.55M0-18.55M
Gain on sale of security --2.35M---268K--707K----------------------------
Other non- operating income (expenses) 25.81%-23K377.36%147K-197.50%-195K---31K---53K101.08%200K-----3,989.52%-18.55M--0---18.55M
Income before tax 8.35%-14.54M16.47%-13.96M52.65%-27.62M-15.86M-37.88%-16.72M18.78%-58.34M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M
Income tax 35.85%72K53K
Net income 8.35%-14.54M16.47%-13.96M52.57%-27.7M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M
Net income continuous Operations 8.35%-14.54M16.47%-13.96M52.57%-27.7M---15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M---42.72M
Minority interest income
Net income attributable to the parent company 8.35%-14.54M16.47%-13.96M52.57%-27.7M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.35%-14.54M16.47%-13.96M52.57%-27.7M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M
Basic earnings per share 63.15%-0.624416.56%-1.4950.78%-3.07-1.6943-37.88%-1.785718.71%-6.23771.62%-1.2951-299.23%-7.6723-92.08%-1.2169-4.5636
Diluted earnings per share 63.15%-0.624416.56%-1.4950.78%-3.07-1.6943-37.88%-1.785718.71%-6.23771.62%-1.2951-299.23%-7.6723-92.08%-1.2169-4.5636
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+0.09%